Precision Medicine — Personalized, Problematic, and Promising
Authors:
- J. Larry JamesonJJJ. Larry Jameson
- Dan L. LongoDLDan L. Longo
Top Cited Papers
- 4 June 2015
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 372 (23) , 2229-2234
Abstract
This article considers the growing recognition of precision medicine by clinicians, patients, the pharmaceutical industry, and policymakers and summarizes how this rapidly accelerating field will leave a major imprint on the practice of medicine.Keywords
This publication has 37 references indexed in Scilit:
- A New Initiative on Precision MedicineNew England Journal of Medicine, 2015
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia BNew England Journal of Medicine, 2014
- Therapy of Hepatitis C — Back to the FutureNew England Journal of Medicine, 2014
- Urinary-Cell mRNA Profile and Acute Cellular Rejection in Kidney AllograftsNew England Journal of Medicine, 2013
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Acute HIV-1 InfectionNew England Journal of Medicine, 2011
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994